loading...
Sandbag: Painful Sex
Showing posts with label Painful Sex. Show all posts
Showing posts with label Painful Sex. Show all posts

Monday, July 22, 2013

Many women don't realize painful sex is common, treatable condition

Many women suffer from dyspareunia, or painful intercourse, but they may not realize the condition has a name and more importantly treatments.

Women "often feel like it's their fault," Dr. Lynne T. Schuster, a physician at Mayo Clinic's Women's Health Clinic in Rochester, Minn., said to CBSNews.com. "There could be so much less suffering."

Dyspareunia -- which can occur just before, during or after intercourse -- can be caused by many physical and psychological conditions. Schuster estimates that the condition is so pervasive that at least 40 percent of all women will experience it in their lifetime.

For many women of all ages, vulvodynia may the culprit for their condition. Women with vulvodynia experience chronic burning or irritation at the opening or inside of the vagina. This could be caused by involuntary contractions of the vaginal muscles. Yeast infections or pelvic inflammatory disease can lead to painful sex as well.

Women who have just given birth may also experience dyspareunia, and may need more time to heal.

Another cause could be menopause. Older women going through menopause often experience painful sex because of lower levels of estrogen. Lower amounts of the hormone lead to vaginal and genital tissue getting thinner.

Actress Virginia Madsen ("Sideways," "The Number 23") became interested in speaking out about dyspareunia after she realized there not a lot of information out there about menopause and its related conditions. She has partnered with the pharmaceutical company Shionogi Inc's Finding the Words campaign to help educate women about dyspareunia and other conditions. Shionogi Inc. manufactures Osphena, a treatment for post-menopausal dyspareunia.

"I think what surprised me mostly, honestly, is that so many women were silent about it," she said." I just found that in this day and age that was really surprising. When you look at the way we relate to our doctors as women, a lot of women just don't -- they just go in and out. Some women don't even get their annual (check-up)."

"Sometimes women will say they don't want to seem like they are complaining," she added. "They'll downplay symptoms so they can just get on with things and concentrate on everybody else except them."

Dr. Jennifer Wu, an OB/GYN at Lenox Hill Hospital in New York City, pointed out that many women will go see their doctor if they start experiencing pain during sex that they didn't feel before.  But many other women who are going through menopause may think it's just a normal side effect and not seek help.

"They might be more reluctant to talk to it from a generational perspective," Wu said. "Older women are just shy about talking about painful sex."

One concern Wu has is that many post-menopausal women may stop having sex for a few months, or entirely, once they start feeling pain. This will only exacerbate the condition, she said. Wu pointed out doctors can recommend non-invasive treatments like lubricants, moisturizers and hormonal creams that can help these women if they just bring up the issue.

For some women, it may be as simple as teaching them how to relax their pelvic floor muscles, said Dr. Schuster of the Mayo Clinic. She encourages women to go see a specialist if they feel they might have the condition.

Madsen understands that it might be uncomfortable for some women to talk about their condition. She suggested looking up information on dyspareunia and taking notes, help women can feel more comfortable asking their doctors questions. If going to a doctor is too daunting, she suggested talking to a female friend or partner.

There's no shame in telling your partner about your condition, said Madsen.

"There's a lot of women who had symptoms of this for years, and they haven't talked to their partner," she explained. "And they don't know what's going on either, and you can imagine what effect that would have on a relationship."

For more information on dyspareunia, visit the Mayo Clinic's website.

Source: cbsnews.com

Monday, April 29, 2013

FDA Approved Osphena: A New Medication for Painful Sex in Postmenopausal Women

Look What's New
Ospemifene (brand name Osphena) is a medication recently approved by the FDA for dyspareunia treatment in postmenopausal women. The medication will be available in June, 2013.

Dyspareunia is a broad term meaning painful sex in females. There are many causes of dyspareunia. One major cause is menopause. During menopause, a woman's body stops producing estrogen and progesterone. This results in thinning of the vaginal lining, with dryness, itching, burning, discharge, and even cracking, resulting in pain during sexual intercourse. Up to 40% of postmenopausal women may have these symptoms, a clinical sydrome also known as atrophic vaginitis. Ospemifene mimics the action of estrogen on the vagina. In some ways it may be a "pink Viagra", because it can enable an older person who is unable to have sex due to a medical condition to be able to enjoy sex again.

Comparing ospemifene with other treatments for dyspaureunia
:

1) Vaginal lubricants. This is by far the safest option, outside of doing nothing. Using a lubricant such as Replens or Astroglide 2-3 times a week can be helpful for some women, but it is not as effective as hormone replacement. Vaginal lubricants can also be messy and inconvenient.

2) Estrogen/progesterone replacement. This is highly effective, and can take a variety of forms, including pills, vaginal creams, and dissolving vaginal rings. Typically, taking pills is reserved for patients who also have disabling hot flashes, as estrogen and progesterone by mouth raises the risk for breast cancer, stroke, and blood clots.

We do not know for sure about the risks for these complications for hormones delivered via the vagina. It is thought that the risk is less than for orally given hormones.

"Bioavailable" hormones have been popularly promoted to be safer than conventional hormone replacement but there is no scientific data supporting this claim.

3) Ospemifene. This is also very effective. The advantages of ospemifene over hormone replacement are unclear, except you take it by mouth instead of in the vagina. This may be important if you have a hard time manipulating a ring or reaching your vagina (if you have severe hand/wrist/elbow arthritis, or if you are obese, for example).

The current studies of ospemifine are not large enough to compare the risks of breast cancer, blood clots and strokes with hormone replacement.

You should not take ospemifene if:

1) You are not menopausal. If you are still having your monthly cycle, then your own body's hormones will work better than ospemifene.

2) Your main problem is low libido and your vagina does not hurt. Ospemifeme does not treat libido, only vaginal pain, and it does have side effects.

3) Your pain is not from a thin vaginal lining. A regular pelvic exam can easily tell your provider whether you have atrophic vaginitis.

4) Your pain is adequately relieved by vaginal lubricants. These methods carry less risk for side effects. Unfortunately, alternative medicine therapies such as herbs and soy do not seem to work for this condition.

5) You have vaginal bleeding and you do not know the cause. Ospemifene was studied for only one year in a limited number of patients before gaining FDA approval. Although there were no cases of endometrial cancer during that one year, ospemifene could cause an existing cancer to grow. We do not know whether there may be a slight increase in the risk of endometrial cancer, particularly over longer periods of use.

6) You have had or currently have breast cancer. Ospemifene has been shown to possibly retard the growth of breast cancer in animals. It did not seem to cause breast cancer in the clinical trials leading to FDA approval. However, this is not proof that it is safe enough to use in breast cancer patients.

7) You have severe hot flashes. Ospemifene has been shown to worsen hot flashes. If you don't think you could handle hot flashes worse than the ones you have now, this is not the drug for you.

References:

Bachman, Gloria A., and Nicole S. Nevadunsky. "Diagnosis and Treatment of Atrophic Vaginitis." American Family Practitioner 61.10 (2000): 3090-096. Print.

Hill, D. Ashley, and Susan Hill. "Counseling Patients About Hormone Therapy and Alternatives for Menopausal Symptoms." American Family Practitioner 82.7 (2010): 801-07. Print.

Portman, D. J., G. A. Bachmann, J. A. Simon, and Ospemifene Study Group. "Ospemifene, a Novel Selective Estrogen Receptor Modulator for Treating Dyspareunia Associated with Postmenopausal Vulvar and Vaginal Atrophy." Menopause (n.d.): n. pag. 28 Jan. 2013. Web.

Simon, J. A., V. H. Lin, C. Radovich, G. A. Bachmann, and Ospemiifene Study Group. "One-year Long-term Safety Extension Study of Ospemifene for the Treatment of Vulvar and Vaginal Atrophy in Postmenopausal Women with a Uterus." Menopause(n.d.): n. pag. 8 Nov. 2012. Web.

http://voices.yahoo.com/is-osphena-me-look-medication-painful-12042761.html?cat=70


Flexoplex